Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Evolus Inc
NASDAQ:EOLS
|
US |
|
IPCA Laboratories Ltd
NSE:IPCALAB
|
IN |
|
W
|
WesBanco Inc
NASDAQ:WSBC
|
US |
|
H
|
Heidelberg Materials AG
F:HEIU
|
DE |
|
Duolingo Inc
NASDAQ:DUOL
|
US |
|
V
|
Venture Global Inc
NYSE:VG
|
US |
Dividends
Dividend Yield
Regeneron Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Regeneron Pharmaceuticals Inc
REGN have decreased by 0%.
Payout Ratio
Regeneron Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for REGN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
REGN Price
Regeneron Pharmaceuticals Inc
| Average Annual Return | 10.2% |
| Standard Deviation of Annual Returns | 21.24% |
| Max Drawdown | -60% |
| Market Capitalization | 76.5B USD |
| Shares Outstanding | 105 720 000 |
| Percentage of Shares Shorted | 2.86% |
